Liên Minh Châu Âu -
Tiếng Đan Mạch -
EMA (European Medicines Agency)
visudyne
cheplapharm arzneimittel gmbh - verteporfin - myopia, degenerative; macular degeneration - oftalmologiske - visudyne er indiceret til behandling af:voksne med exudative (våd) aldersrelateret macula degeneration (amd) med overvejende klassisk subfoveal choroidal neovascularisation (cnv), eller voksne med subfoveal choroidal neovascularisation sekundær til patologisk nærsynethed.
Liên Minh Châu Âu -
Tiếng Đan Mạch -
EMA (European Medicines Agency)
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andre antineoplastiske midler - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
Liên Minh Châu Âu -
Tiếng Đan Mạch -
EMA (European Medicines Agency)
ogluo
tetris pharma b.v - glucagon - diabetes mellitus - pancreas hormoner, hormoner glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
Liên Minh Châu Âu -
Tiếng Đan Mạch -
EMA (European Medicines Agency)
skysona
bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - andre narkotika stoffer - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.
Liên Minh Châu Âu -
Tiếng Đan Mạch -
EMA (European Medicines Agency)
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - multipelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
Đan Mạch -
Tiếng Đan Mạch -
SEGES Landbrug & Fødevarer
lfs metconazol/mepiquat-chlorid vandopløseligt koncentrat
lfs kemi - metconazol, mepiquat-chlorid, mepiquat - vandopløseligt koncentrat - 30 g/l metconazol ; 210 g/l mepiquat-chlorid ; (~ 160 g/l mepiquat